Hinjewadi, India

Juber Abdulhamid Shaikh

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juber Abdulhamid Shaikh. Retrieved from https://idiyas.com/inventor/juber-abdulhamid-shaikh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Juber Abdulhamid Shaikh

Introduction

Juber Abdulhamid Shaikh is a notable inventor based in Hinjewadi MIDC, India. He has made significant contributions to the field of biotechnology, particularly in the development of nucleotides and oligonucleotides.

Latest Patents

One of his key inventions is related to 5'S-LNA nucleotides and oligonucleotides. The patent describes a compound of formula (I) wherein R2 and R4 are joined and together form a group, such as —CH2O—. This compound can be utilized in the manufacture of 5'S-LNA oligonucleotides as antisense drugs. Juber holds 1 patent for this innovative work.

Career Highlights

Juber Abdulhamid Shaikh is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on advancing drug development through innovative biotechnological solutions.

Collaborations

He has collaborated with notable colleagues, including Konrad H Bleicher and Joerg Duschmalé, to further enhance the impact of his research and inventions.

Conclusion

Juber Abdulhamid Shaikh's contributions to biotechnology, particularly through his patent on 5'S-LNA nucleotides and oligonucleotides, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in antisense drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…